TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment December 4, 1998
TCL Archive Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs” April 27, 2012
